PIPELINE

hOTX2 for Glaucoma

An OTX2-based therapy has a potential to become a treatment for glaucoma. OTX2 has been shown to be a maintenance and survival factor for retinal ganglion cells, those that degenerate in glaucoma and are responsible for the vision loss. Preliminary proof-of-concept has been established in preclinical models (ref).

hOTX2 for Glaucoma

An OTX2-based therapy has a potential to become a treatment for glaucoma. OTX2 has been shown to be a maintenance and survival factor for retinal ganglion cells, those that degenerate in glaucoma and are responsible for the vision loss. Preliminary proof-of-concept has been established in preclinical models (ref).